Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2793-2026

SafeOp Patient Interface, REF: AIX11240, part of SafeOp 3: Neural Informatix System Recall

SafeOp Patient Interface, REF: AIX11240, part of SafeOp 3: Neural Informatix System

FDA recall Class II

Ongoing

FDA lists this Class II recall for SafeOp Patient Interface, REF: AIX11240, part of SafeOp 3: Neural Informatix System. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2793-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
May 13, 2026
FDA report date
Jul 29, 2026
Quantity in commerce
3
Distribution
See key details
FDA cause
Software Design Change

What is being recalled?

SafeOp Patient Interface, REF: AIX11240, part of SafeOp 3: Neural Informatix System

Affected model & UDI checker

Search the exact identifiers published for Z-2793-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
AIX11240SafeOp Patient Interface, REF: AIX11240, part of SafeOp 3: Neural Informatix SystemCheck source noticeNot specified
Not specifiedSafeOp Patient Interface, REF: AIX11240, part of SafeOp 3: Neural Informatix SystemCheck source notice00190376517506
FDA code information

UDI-DI: 00190376517506. System Set ID/Patient Interface Serial Number: 2007716/ DG106225, 2005498/ DG106220, 2005490/ DG106230

View the original FDA recall notice

Why was this product recalled?

Intraoperative neuromonitoring device, due to a software issue, may experience loss or interruption of triggered electromyography (tEMG) functionality during use, displaying as system faults, loss of communication between the Patient Interface and Tablet, and prompts requiring system reboot; may result in increased operative time and surgical plan change.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Alphatec Spine, Inc. take?

On 5/13/2026, recall notices were emailed to customers who were advised of the following: 1) Recalling firm has provided replacement SafeOp 3 Systems. 2) Abstain from using affected devices and return to recalling firm. 3) Share this notice within your organization or any organization where the affected device(s) has(have) been transferred. 4) Fill out the last page of this letter to confirm that you have read this notification and have taken all necessary actions, as described in this notification. If you have any questions/concerns or require assistance with the recall, please e-mail QMSCompliance@atecspine.com or call 1-800-922-1356.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

Product / regulatory recordCompanyPathwayDecision dateSource
Alphatec Spine, Inc.510(k) clearanceJan 11, 2026FDA

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology